Opportunity
SAM #6912710440008
VA award for emergency Pluvicto and Lutathera radiopharmaceuticals
Buyer
VA 262 Network Contract Office 22
Posted
October 29, 2026
Identifier
6912710440008
NAICS
325412, 424210
The Department of Veterans Affairs awarded an emergency, one-month bridge order to support cancer care at the VA Greater Los Angeles Healthcare System. - Government buyer: Department of Veterans Affairs; VA Greater Los Angeles Healthcare System; Network Contracting Office 22. - Awarded vendor and OEM: Novartis Pharmaceuticals Corporation, identified as the sole authorized source listed in the VA NAC catalog. - Products requested: - Pluvicto radiopharmaceutical radioligand therapy; quantity and part number not stated. - Lutathera radiopharmaceutical radioligand therapy; quantity and part number not stated. - Purpose and requirements: Emergency bridge delivery to maintain continuity of cancer care while the longer-term order is finalized. The justification cites urgent patient-care needs and the medications’ proprietary, specialized nature. - Award amount: $769,496.80. Per-injection prices are not provided.